デフォルト表紙
市場調査レポート
商品コード
1678779

心電図パッチ・ホルターモニターの世界市場 (2025年~2033年)

Global ECG Patches and Holter Monitor Market - 2025-2033


出版日
ページ情報
英文 220 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
心電図パッチ・ホルターモニターの世界市場 (2025年~2033年)
出版日: 2025年03月11日
発行: DataM Intelligence
ページ情報: 英文 220 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の心電図パッチ(ECGパッチ)およびホルターモニターの市場は、2024年に18億6,454万米ドルに達し、2033年には59億5,062万米ドルに達すると予測され、2025~2033年の予測期間中にCAGR 13.7%で成長すると予測されています。

心電図パッチとホルターモニターは、不規則な心臓リズムを検出するための連続心臓モニタリングに使用されるウェアラブル医療機器です。心電図パッチは24~72時間にわたって心臓の活動を記録し、ホルターモニターは長期モニタリング用に設計されたポータブルでバッテリー駆動のデバイスです。これらのデバイスは、医療提供者による心臓機能の分析、心血管系の状態の診断、患者の遠隔モニタリングを支援し、心臓疾患の早期発見と管理を改善します。

市場力学:

促進要因と抑制要因

ウェアラブル・遠隔モニタリングデバイスの採用増加

世界の心電図パッチとホルターモニター市場は、特に心血管疾患の有病率の増加とデジタルヘルス技術の進歩によるウェアラブル・遠隔モニタリングデバイスの増加によって牽引されています。ウェアラブル心電図パッチはリアルタイムのデータ伝送を提供し、医療提供者が遠隔で心臓の異常を検出できるようにします。AIとクラウドベースのアナリティクスの統合は、早期診断と患者の転帰をさらに強化します。市場拡大の原動力となっているのは、特に高齢者や慢性疾患を抱える人々の間で在宅医療が好まれることです。

例えば、2024年3月、サムスンから分離独立したデジタル医療企業のWellysisは、米国でArtella Solutionsと提携して遠隔心臓モニタリングサービスを開始しました。この提携は、ウェリシスのFDA認可のS-Patch心電図モニタリング・ソリューションに基づくもので、現在はFDA認可のS-Patch ExLデバイスを搭載しています。ExLモデルは、コイン電池1個で約14日間の長期検査が可能で、2月初旬にFDA認可を受けた。この拡張により、Wellysisは拡張ホルターサービスとモバイル心臓テレメトリーサービスにおけるリーチを拡大することができます。

高コストと償還の課題

心電図パッチやホルターモニターに関連する高コストも、予測期間中、市場の妨げになると予想されます。これらの製品に関連する高コストは、医療システム、病院、診断クリニックに大きな財政負担を強いる可能性があります。予算の制約により、特に資源が限られた環境では、心電図パッチやホルターモニターの普及が制限される可能性があります。

目次

第1章 分析手法と分析範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ウェアラブルデバイスや遠隔モニタリングデバイスの導入増加
    • 抑制要因
      • 高額な費用と償還の課題
    • 機会
    • 影響分析

第5章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と主要企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析:ベストケース・ベースケース・ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー (KOL)

第6章 装置の種類別

  • 心電図パッチ (ECGパッチ)
  • ホルターモニター

第7章 用途別

  • モニタリング
  • 診断

第8章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター
  • 診断センター
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Koninkluke Philips N.V.
    • 企業概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標(KPI)
      • 製品販売の実績・予測
      • 製品販売量
    • 財務概要
      • 企業の収益
      • 収益シェア:地域別
      • 収益予測
    • 主な発展
      • 企業合併・買収 (M&A)
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Bittium
  • Meditech Equipment Co., Ltd
  • ACS Diagnostics
  • Viatom Application Co., Ltd.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Spacelabs Healthcare, Inc.
  • SmartCardia Inc.
  • dms-service LLC
  • Similar data will be provided for each market player.
  • ReelCardio LLC
    • パイプライン製品の説明
    • 製品の主要業績評価指標(KPI)
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上予測と予測
  • Bardy Diagnostics
  • AliveCor
  • Cardiac Insight
  • 各市場参入企業に対しても同様のデータが提供されます。

第12章 付録

目次
Product Code: MD7215

The Global ECG Patches and Holter Monitor Market reached US$ 1,864.54 million in 2024 and is expected to reach US$ 5,950.62 million by 2033, growing at a CAGR of 13.7% during the forecast period of 2025-2033.

ECG patches and Holter monitors are wearable medical devices used for continuous cardiac monitoring to detect irregular heart rhythms. ECG patches record heart activity over 24 to 72 hours, while Holter monitors are portable, battery-operated devices designed for long-term monitoring. These devices aid healthcare providers in analyzing heart function, diagnosing cardiovascular conditions, and enabling remote patient monitoring, improving early detection and management of heart diseases.

Market Dynamics: Drivers & Restraints

Increasing Adoption of Wearable and Remote Monitoring Devices

The global ECG patches and Holter monitor market is driven by the rise in wearable and remote monitoring devices, particularly due to the increasing prevalence of cardiovascular diseases and digital health technology advancements. Wearable ECG patches provide real-time data transmission, enabling healthcare providers to detect cardiac abnormalities remotely. The integration of AI and cloud-based analytics further enhances early diagnosis and patient outcomes. The market's expansion is driven by the preference for home-based healthcare, especially among the elderly and those with chronic conditions.

For instance, in March 2024, Wellysis, a digital healthcare company spun off from Samsung, launched a remote cardiac monitoring service in the US in partnership with Artella Solutions. The partnership builds on Wellysis' FDA-cleared S-Patch electrocardiogram monitoring solution, now featuring the FDA-cleared S-Patch ExL device. The ExL model allows for extended testing periods of about 14 days on a single coin battery and received FDA clearance in early February. This expansion enables Wellysis to expand its reach in the Extended Holter service and Mobile Cardiac Telemetry service.

High Cost and Reimbursement Challenges

The high costs associated with the ECG patches and Holter monitors is also expected to hamper the market over the forecast period. High costs associated with these products may impose a significant financial burden on healthcare systems, hospitals and diagnostic clinics. Budget constraints could limit the widespread adoption of ECG patches and Holter monitors, especially in resource-limited settings.

Segment Analysis

The global ECG patches and holter monitor market is segmented based on device type, application, end user and region.

Device Type:

ECG Patches in the device type segment are expected to dominate with the highest market share

ECG patches are a user-friendly, wireless, and comfortable alternative to traditional Holter monitors in cardiac monitoring. They provide continuous heart rhythm tracking, enabling early detection of arrhythmias and other cardiovascular conditions. The increasing adoption of ECG patches is driven by AI-powered analytics, cloud-based data sharing, and improved battery life. Their integration into home healthcare and ambulatory care settings reduces hospital visits and improves patient compliance.

ECG patches store data that can be later analyzed by healthcare professionals. This data provides a comprehensive overview of the patient's heart activity, aiding in accurate diagnosis and personalized treatment plans. ECG patches are increasingly being used as an alternative to traditional Holter monitors, offering a more discreet and comfortable option for prolonged heart monitoring. Patients can continue their daily activities without disruption while wearing these patches.

Geographical Analysis

North America is expected to hold a significant position in the ECG Patches and Holter Monitor market share.

North America is a major player in the global ECG patches and Holter monitor market due to the increasing prevalence of cardiovascular diseases, the geriatric population, and increased healthcare expenditure. The region's advanced healthcare infrastructure, favourable reimbursement policies, and technological advancements in wearable cardiac monitoring devices drive market growth. The presence of major market players and their innovative product launches and increased awareness about remote patient monitoring and early disease detection further enhance adoption rates.

Europe is growing at the fastest pace in the ECG Patches and Holter Monitor market.

Europe is driving the growth of the ECG patches and Holter monitor market due to healthcare digitization, government initiatives, and preventive healthcare. The aging population and improved healthcare access support the market's expansion. The adoption of wearable and AI-driven technologies, along with a well-established regulatory framework, further strengthens market penetration. Key medical technology companies and ongoing research into innovative diagnostic solutions further strengthen Europe's role in driving market growth.

For instance, in May 2024, Royal Philips successfully launched its ambulatory cardiac monitoring service in Spain using a wearable ePatch and the Cardiologs analytics platform. The service uses Holter monitors to detect life-threatening heart arrhythmias, improve patient comfort, and potentially improve clinical outcomes.

Competitive Landscape

The major global players in the ECG Patches and Holter Monitor market include Koninkluke Philips N.V, Bittium, Meditech Equipment Co., Ltd, ACS Diagnostics, Viatom Technology Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., Spacelabs Healthcare, Inc, SmartCardia Inc, and dms-service LLC, among others.

Key Developments

  • In May 2024, Vivalink, a leading provider of digital healthcare solutions, launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ECG Patches and Holter Monitor market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Device Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Wearable and Remote Monitoring Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Reimbursement Challenges
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Device Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 6.1.2. Market Attractiveness Index, By Device Type
  • 6.2. ECG Patches*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Holter Monitors

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Monitoring*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Diagnostics

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Diagnostic Centers
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Koninkluke Philips N.V.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Bittium
  • 11.3. Meditech Equipment Co., Ltd
  • 11.4. ACS Diagnostics
  • 11.5. Viatom Application Co., Ltd.
  • 11.6. GE HealthCare Technologies Inc.
  • 11.7. Hill-Rom Holdings, Inc.
  • 11.8. Spacelabs Healthcare, Inc.
  • 11.9. SmartCardia Inc.
  • 11.10. dms-service LLC
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. ReelCardio LLC*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Bardy Diagnostics
  • 11.13. AliveCor
  • 11.14. Cardiac Insight
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us